| Line Item | 2023-01-31 | Y/Y |
|---|---|---|
| Revenue | $618.2M | +25.5% |
| Cost of Revenue | $163.7M | +11.0% |
| Gross Profit | $454.5M | +31.8% |
| R&D Expense | $76.7M | +26.5% |
| SG&A Expense | $92.3M | +8.9% |
| Operating Income | -$51.2M | +48.5% |
| Pre-tax Income | -$47.5M | +54.6% |
| Income Tax | $8.3M | +19.6% |
| Net Income | -$55.7M |
| Line Item | 2023-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $188.4M | -41.4% |
| Current Assets | $862.5M | +7.1% |
| Total Assets | $1.02B | +11.4% |
| Current Liabilities | $458.9M | +16.2% |
| Total Liabilities | $475.7M | +17.7% |
| Stockholders' Equity | $549.3M | +6.5% |
| Line Item | 2023-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $26.7M | +181.0% |
| Capital Expenditures | $6.1M | -0.9% |
| Investing Cash Flow | -$193.5M | -1136.4% |
| Financing Cash Flow | $35.0M | -88.5% |
| Free Cash Flow | $20.6M | +152.6% |
| +50.0% |
| EPS (Basic) | -$0.21 | +63.2% |
| EPS (Diluted) | -$0.21 | +63.2% |